Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma

Clinical trial NCT02739594 · TERMINATED

Trial details

NCT number: NCT02739594
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2006-02-01
Primary completion: 2009-04-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.